Home » Newsletters » BioWorld Asia

BioWorld Asia

Dec. 23, 1998

View Archived Issues

Oxford BioMedica, RPR In £11 million Deal

Mologen, Virbac Enter Agreement For Vaccines

Australian Food Industry Assails Labeling Decision

British Biotech Drops One Marimastat Study

Early Progen Study Finds Enzyme Blocker Effective

Antisoma Raises £10M, Achieves Market Listing

Australia's Biotech Market Lacks Depth, Analysts Say

Xenova Plans Phase II Study Of Cancer Drug

Chiroscience Mulls Strategy For Anesthetic's Marketing

Other News To Note